DRUGS related term(s) Crime

Addresses

Assistance to Countries Seriously Affected by HIV/AIDS: Representative Sanders, E908-E910 [9MY]

Advertisements

Pharmaceutical Market Access Act (H.R. 2427): TREA Senior Citizens League, H9466 [15OC]

Amendments

Crime: foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (S. 1194), S13317 [27OC]

Diseases: expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), S6445, S6449, S6476, S6478, S6481, S6484, S6486, S6531, S6532, S6562, S6563, S6564, S6565, S6566 [15MY], H3575, H3588, H3596, H3600, H3601, H3602, H3603, H3604, H3605, H3608, H3609, H3612 [1MY], H4375 [21MY]

FDA: provide authority to require certain research into drugs used in pediatric patients (S. 650), S9809, S9811, S9815 [23JY]

Federal Food, Drug, and Cosmetic Act: establish a program of fees relative to animal drugs (S. 313), S7165 [23MY], S7262 [3JN], S14279 [7NO]

Hazardous substances: provide assistance for poison prevention and stabilize funding of regional poison control centers (S. 686), S8316 [20JN]

Medicare: reform and provide prescription drug coverage (H.R. 1), S8898 [7JY], H5912, H5929, H5930, H5939 [25JN], H6121 [26JN]

———reform and provide prescription drug coverage (H.R. 1), consideration (H. Res. 299), H5963 [26JN]

———reform and provide prescription drug coverage (H.R. 1), consideration of conference report (H. Res. 463), H12245 [21NO]

———reform and provide prescription drug coverage (S. 1), S7932 [16JN], S8020, S8089, S8105, S8111, S8161, S8162 [18JN], S8173, S8174, S8182, S8184, S8203, S8246, S8247, S8248, S8249, S8252, S8253, S8255 [19JN], S8273, S8278, S8283, S8284, S8285, S8286, S8288, S8290, S8291, S8308, S8309, S8310, S8311, S8312, S8313, S8314 [20JN], S8325, S8330, S8331, S8335, S8336, S8337, S8340, S8341, S8345, S8348, S8350, S8351, S8353, S8367, S8368, S8369, S8370, S8371, S8372, S8374, S8375, S8376 [23JN], S8387, S8390, S8396, S8400, S8404, S8405, S8410, S8415, S8416, S8418, S8421, S8422, S8423, S8424, S8446, S8447, S8448, S8449, S8450, S8451, S8457, S8459, S8460, S8461, S8463, S8464, S8470, S8472, S8473, S8474, S8475, S8476 [24JN], S8480, S8483, S8487, S8489, S8495, S8496, S8500, S8502, S8512, S8515, S8516, S8521, S8522, S8536, S8538, S8539, S8578, S8579, S8580, S8581, S8582, S8583, S8584, S8585, S8586, S8587, S8588, S8589, S8590, S8592, S8593, S8594 [25JN], S8608, S8610, S8612, S8617, S8621, S8624, S8625, S8630, S8632, S8633, S8636, S8639, S8644, S8654, S8655, S8666, S8675, S8679, S8680, S8681, S8682, S8683, S8684, S8685, S8766, S8767, S8768, S8769, S8773, S8775, S8776, S8777, S8778, S8779, S8780, S8781, S8782, S8795, S8796 [26JN], S8898 [7JY]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 285), S9819 [23JY]

Analyses

Gang Prevention and Effective Deterrence Act (S. 1735), S12616-S12618 [15OC]

Appointments

Conferees: H.R. 1, Medicare Prescription Drug and Modernization Act, H6681 [14JY]

———H.R. 1, Prescription Drug and Medicare Improvement Act, S8898 [7JY]

Senate Caucus on International Narcotics Control, S9823 [23JY], S9924 [24JY]

Articles and editorials

AARP Accused of Conflict of Interest, H12254 [21NO]

AARP Calls on Vermont Congressional Delegation To Vote for Medicare Rx Bill, S15694 [24NO]

AIDS Fuels Famine in Africa as Swaziland Farmers Die, Their Land Goes Unplanted, S9214 [10JY]

Chicago Democratic Mayor Richard Daley on Anti-Gang Loitering Statutes, S2098 [10FE]

Drug Maker Pushed Painkiller Aggressively; Purdue PHARMA Has Marketed OxyContin Far Beyond Its Original Purpose, Newly Released Documents Show, E1246 [13JN]

Drug Plan a Placebo, H7234 [22JY]

Drugmakers Protect Their Turf—Medicare Bill Represents Success for Pharmaceutical Lobby, H12110 [21NO]

Flu Shots Save Lives, S5531 [30AP]

Health on the Border—Elderly Americans Head North and South To Find Drugs They Can Afford, H5347 [12JN]

Hobson's Medicare, S15536 [22NO], S15897 [25NO]

In Another Break With Past, Kenyans See Hope on AIDS, H4381 [21MY]

Long Lines Mar Canada's Low-Cost Health Care, H1693 [11MR]

Medco Accused of Favoring Merck Drugs, S8615 [26JN]

Medicare Bill Would Enrich Companies, S15724 [24NO]

Medicare Debate Turns to Pricing of Drug Benefits, S15735 [24NO]

Medicare Drug Folly, S7971 [17JN]

Medicare Reform—Try Again, S15909 [25NO]

Open Door to Drug Imports, H10540 [6NO]

Patients in Florida Lining Up for All That Medicare Covers, H9178 [2OC]

Prescription Drug Benefit Imminent, H6087 [26JN]

Some Successful Models Ignored as Congress Works on Drug Bill, S11074 [4SE]

Struggling Seniors, Medicare Drug Plan's Proof Is in the Purse, S8658 [26JN]

Traditional Coast Guard Duties Suffer, Study Says, S4679 [2AP]

U.S. Is Joining Lawsuit That Says Medco Put Profits Before Patients, S8614 [26JN]

U.S. Joining Suit Against Medco, S8614 [26JN]

When Half a Loaf Isn't Nearly Enough, S15606 [23NO]

Wrong Prescription—Congress Considers Inadequate Bills, S8659 [26JN]

Youth Program Is Best Revenge Against Rising Tide of Gun Deaths, S1800 [30JA]

Bills and resolutions

AARP: decision to support Medicare reform legislation (see H. Res. 461), H11702 [20NO]

Agency for Healthcare Research and Quality: collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries (see H.R. 2161), H4367 [20MY]

Agriculture: prohibit open-air cultivation or use of human food or animal feed as host plant and establish tracking system to regulate genetically engineered pharmaceutical and industrial crops (see H.R. 2921), H7782 [25JY]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (see S. 946), S5484 [29AP]

Armed Forces: prescription drug benefits for Medicare-eligible enrollees under defense health care plans (see H.R. 3390), H10129 [29OC]

Business and industry: permit biomedical research corporations to engage in certain equity financings without incurring limitations on net operating loss carryforwards and certain built-in losses (see S. 1773), S13053 [22OC] (see H.R. 2968), H7784 [25JY]

Children and youth: protect health by ensuring that chickens and chicken products purchased for national school nutrition programs have not been fed or administered fluoroquinolone antibiotics (see H.R. 3022), H8016 [5SE]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses (see H.R. 345), H169 [27JA]

Colleges and universities: provide grants to States to establish partnerships among colleges and universities and surrounding communities to reduce underage and binge drinking and illicit drug use by students (see S. 406), S2457 [13FE]

Consumers: correct impediments to allowing importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use (see H.R. 780), H700 [13FE]

———establish fairer pricing for prescription drugs for individuals without access to discounted prices (see H.R. 1694), H3051 [9AP]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans (see S. 1396), S9303 [11JY] (see H.R. 2727), H6867 [15JY]

Controlled Substances Act: amend relative to placing of certain substances on the schedules of controlled substances (see H.R. 207), H59 [7JA]

Correctional institutions: require minimum work week, job training, and life skills preparation for Federal prison inmates and establish a grant program for mandatory drug testing (see S. 672), S4165 [20MR]

Courts: authorize grants for establishment of quasi-judicial campus drug courts at colleges and universities (see S. 399), S2457 [13FE]

Crack cocaine: eliminate certain mandatory minimum penalties for offenses (see H.R. 1435), H2311 [25MR]

Crime: foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (see S. 1194), S7476 [5JN] (see H.R. 2387), H5045 [5JN]

———increase mandatory minimum penalties for possessing, brandishing, or discharging a firearm during and in relation to a crime of violence or drug trafficking crime (see H.R. 291), H136 [8JA]

———prohibit opening, maintaining, managing, controlling, renting, leasing, making available for use, or profiting from any place for the purpose of manufacturing, distributing, or using any controlled substance (see S. 226), S1668 [28JA] (see H.R. 718), H460 [12FE]

———provide penalties for open air drug markets (see H.R. 404), H217 [28JA]

———reduce criminal gang activities (see S. 1735), S12607 [15OC]

———respond to the illegal production, distribution, and use of methamphetamines (see H.R. 834), H703 [13FE]

Cuba: make exception to trade embargo for food, medicines, and goods and services intended for children, lift travel restrictions, and provide scholarships for certain Cuban nationals (see H.R. 3422), H10236 [30OC]

DEA: anniversary (see S. Res. 263), S14271 [7NO] (see H. Res. 412), H9812 [21OC]

Dept. of Defense: reevaluate necessity and safety of anthrax and smallpox vaccinations for troops (see S. Res. 278), S15976 [25NO]

Dept. of HHS: establish Office of Correctional Health (see H.R. 1993), H3683 [6MY]

———give grant preference to States that require schools to allow students to self-administer medication for asthma or anaphylaxis (see H.R. 2023), H3761 [7MY]

———promulgate regulations for the reimportation of prescription drugs (see S. 1781), S13134 [23OC] (see H.R. 2427), H5266 [11JN]

———promulgate regulations for the reimportation of prescription drugs (H.R. 2427), consideration (see H. Res. 335), H7453 [23JY]

———take action to remove dietary supplements containing ephedrine alkaloids from the market (see S. Res. 260), S14177 [6NO] (see H. Res. 435), H10978 [6NO]

Dept. of HUD: reauthorize the Public Housing Drug Elimination Program (see H.R. 1981), H3682 [6MY]

Dept. of State: enter into negotiations with Cuba to establish cooperation on illicit narcotics control efforts (see H.R. 1432), H2311 [25MR]

———require report on progress made to eradicate poppy cultivation and prevent illicit drug trafficking in Afghanistan (see H.R. 3642), H12309 [21NO]

Dept. of Veterans Affairs: dispense medications to veterans for prescriptions written by private practitioners and provide Medicare coverage to eligible veterans (see H.R. 1309), H1952 [18MR]

———increase the quantity of supply of certain prescriptions furnished to veterans with chronic conditions (see H.R. 1921), H3635 [1MY]

———permit Medicare-eligible veterans to receive an outpatient medication benefit (see S. 1153), S7135 [23MY]

———pilot program to assess benefits of dispensing medications to veterans for prescriptions written by private practitioners (see H.R. 372), H170 [27JA]

———suspend authority to increase drug copayment for treatment of non-service-connected disabilities and increase pension rates for certain surviving spouses (see H.R. 627), H322 [5FE]

Diseases: address the international HIV/AIDS pandemic (see S. 250), S1812 [30JA]

———authorize appropriations for global initiative to combat polio (see H.R. 1892), H3570 [30AP]

———authorize assistance to combat HIV/AIDS pandemic in sub-Saharan Africa and the Caribbean (see H.R. 1857), H3451 [29AP]

———combat polio (see S. Res. 109), S4957 [8AP] (see S. Res. 266), S14804 [12NO] (see H. Res. 20), H60 [7JA]

———establish a comprehensive Federal effort relating to early detection of, treatments for, and prevention of cancer (see S. 1101), S6853 [21MY] (see H.R. 2741), H6868 [15JY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (see S. 1009), S5859 [7MY] (see H.R. 1298), H1908 [17MR]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), consideration (see H. Res. 210), H3571 [30AP]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), corrections in enrollment (see S. Con. Res. 46), S6707 [20MY]

———improve access to HIV/AIDS-related treatments and services in developing countries (see H.R. 2470), H5365 [12JN]

———improve data collection and dissemination between Federal and State registries to enhance the treatment and research of cancer (see S. 1899), S15287 [20NO]

———protect health of individuals receiving smallpox vaccine and provide compensation to and access to care for individuals sustaining injury as a result of smallpox vaccination (see H.R. 865), H704 [13FE]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (see H.R. 1413), H2310 [25MR] (see H.R. 1463), H2470 [27MR] (see H.R. 1770), H3351 [11AP]

———urge Group of Eight members to pledge and contribute a substantial amount to the fight against HIV/AIDS, tuberculosis, and malaria (see H. Con. Res. 180), H4130 [14MY]

Drug-Free Media Campaign Act: improve and authorize (see H.R. 2061), H3973 [9MY]

Economic Growth and Tax Relief Reconciliation Act: freeze and repeal portions of the tax reduction and apply savings to a comprehensive Medicare outpatient prescription drug benefit (see H.R. 2514), H5551 [18JN]

Education: restrict the disqualification of students for drug offenses to those students who committed offenses while receiving student financial aid (see H.R. 696), H391 [11FE]

Families and domestic relations: provide grants for mental health and substance abuse services for women and children who have been victims of domestic or sexual violence (see S. 1809), S13711 [31OC]

FDA: establish restrictions relative to the qualifications of physicians prescribing the abortion drug known as RU-486 (see H.R. 486), H243 [29JA]

———establish voluntary certification program for Internet and mail-order pharmacies and authorize, subject to conditions, importation of prescription drugs from Canada for personal use (see H.R. 2717), H6706 [14JY]

———provide authority to require certain research into drugs used in pediatric patients (see S. 650), S3881 [18MR] (see H.R. 2857), H7615 [24JY]

———require manufacturers of dietary supplements submit reports on adverse experiences with dietary supplements (see S. 722), S4434 [26MR]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (see S. 1930), S15407 [21NO] (see H.R. 3453), H10977 [6NO]

Federal aid programs: collect and assess scientific evidence regarding prescription drugs frequently used in federally funded health programs (see H.R. 2356), H5043 [5JN]

———public participation in establishing locations of substance abuse treatment group homes (see H.R. 2159), H4367 [20MY]

Federal Employees Health Benefits Program: ensure prescription drug coverage for Medicare-eligible enrollees is actuarially equal to benefit offered to general enrollees (see S. 1369), S8862 [27JN] (see H.R. 2631), H6262 [26JN]

Federal Food, Drug, and Cosmetic Act: amend relative to dietary supplements (see H.R. 3377), H9981 [28OC]

———amend relative to dietary supplements containing ephedrine alkaloids (see H.R. 1075), H1515 [4MR]

———amend relative to new animal drugs (see S. 741), S4512 [27MR] (see H.R. 2079), H4011 [13MY]

———establish a program of fees relative to animal drugs (see S. 313), S1977 [5FE] (see H.R. 1260), H1900 [13MR]

———establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors (see H.R. 725), H460 [12FE]

———establish recall authority for drugs and increase criminal penalties for sale or trade of prescription drugs knowingly adulterated or misbranded (see H.R. 3297), H9477 [15OC]

———establish requirements to allow sale of prescription drugs over the Internet (see H.R. 2652), H6263 [26JN]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (see S. 1460), S9959 [25JY] (see H.R. 2932), H7782 [25JY]

———prohibit sale or trade of prescription drugs that were knowingly adulterated or misbranded (see H.R. 2936), H7783 [25JY]

———provide greater access to affordable pharmaceuticals (see S. 7), S34 (see S. 54), S36 [7JA] (see S. 1225), S7619 [10JN] (see H.R. 2491), H5467 [17JN] (see H.R. 2640), H6262 [26JN]

———require manufacturers of dietary supplements to register and require submission of reports on adverse experiences regarding such supplements (see H.R. 724), H460 [12FE]

Foreign aid: authorizing appropriations for foreign assistance programs (see S. 1161), S7381 [4JN]

GAO: conduct a study on price controls of foreign governments on pharmaceuticals (see H.R. 2577), H5813 [24JN]

Government regulations: eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (see S. 1784), S13134 [23OC]

Hazardous substances: prevent inhalant abuse (see H.R. 2873), H7616 [24JY]

———provide assistance for poison prevention and stabilize funding of regional poison control centers (see S. 686), S4275 [21MR] (see H.R. 1819), H3353 [11AP]

Health: improve access to prescription drugs, prohibit tax deductions for direct-to-consumer prescription drug advertisements, and ban campaign contributions from pharmaceutical company chief executive officers (see H.R. 1733), H3301 [10AP]

———improve immunization rates by increasing the distribution of vaccines and improving and clarifying the vaccine injury compensation program (see S. 754), S4629 [1AP]

———improve patient safety and reduce incidence of medical errors (see S. 720), S4434 [26MR] (see H.R. 663), H389 [11FE]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see S. 1410), S9414 [15JY] (see H.R. 2085), H4129 [14MY]

———prevent abuse of ``Ecstasy'' (see H.R. 2962), H7784 [25JY]

———provide compensation for injuries resulting from smallpox countermeasures (see S. 719), S4434 [26MR]

———provide compensation for injuries resulting from smallpox countermeasures, provide protection against chemical or radiological agents, increase distribution of vaccines, and improve vaccine injury compensation (see S. 15), S3504 [11MR]

———reduce price of prescription drugs purchased by States for its employees, retirees, and pharmaceutical assistance beneficiaries (see H.R. 3662), H12918 [8DE]

———require notification by manufacturers before discontinuing production of a vaccine and develop a national vaccine stockpile (see S. 371), S2340 [12FE]

———use of marijuana for medicinal purposes (see H.R. 1717), H3301 [10AP] (see H.R. 2233), H4735 [22MY]

Health care professionals: establish an electronic system for practitioner monitoring of the dispensing of certain controlled substances (see H.R. 3015), H7949 [4SE]

———implement an education loan repayment program for pharmacists (see S. 648), S3881 [18MR] (see H.R. 3591), H12307 [21NO]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (see S. 1887), S15061 [18NO] (see H.R. 3634), H12309 [21NO]

Higher Education Act: repeal provisions prohibiting persons convicted of drug offenses from receiving student financial assistance (see H.R. 685), H390 [11FE]

Homeland Security Act: repeal certain provisions (see S. 41), S36 [7JA]

———repeal certain provisions relative to pediatric vaccine manufacturer liability (see S. 105), S37 [7JA] (see H.R. 248), H135 [8JA]

Immigration: bar admission and facilitate removal of alien terrorists and their supporters, drug traffickers, and other illegal or criminal aliens and reform the visa and legal immigration systems (see H.R. 3522), H11650 [19NO]

Insurance: coverage of prescription drugs (see H.R. 1243), H1811 [12MR]

———grant State high risk pool insurance programs reductions in prices charged for prescription drugs under Public Health Service Act prescription drug pricing agreements (see H.R. 1291), H1901 [13MR]

———prohibit a health plan from contracting with a pharmacy benefit manager (PBM) unless certain requirements are satisfied (see S. 1300), S8232 [19JN]

———provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (see S. 1138), S6978 [22MY] (see H.R. 2256), H4736 [22MY]

———require comprehensive coverage for childhood immunizations (see H.R. 2095), H4130 [14MY]

Japan: urge honoring of commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals (see S. Con. Res. 80), S14335 [10NO] (see H. Con. Res. 324), H11149 [12NO]

Labeling: require that each prescription drug sold at retail bear a label that states full retail price of the drug (see H.R. 3677), H12919 [8DE]

Law enforcement: ensure adequate funding is provided for certain high intensity drug trafficking areas (see H.R. 1599), H2819 [3AP]

———promote rural safety and improve rural law enforcement (see S. 1907), S15287 [20NO] (see S. 1951), S15975 [25NO]

———provide grants for law enforcement training and equipment to combat methamphetamine labs (see H.R. 3092), H8283 [16SE]

McDermott, Ignatius: award Congressional Gold Medal (see H.R. 3148), H8490 [23SE]

Medicaid: allow States to enter into drug rebate agreements to make prescription drugs available to individuals who are not otherwise eligible for medical assistance (see S. 542), S3163 [5MR]

———clarify that inpatient drug prices charged to certain public hospitals are included in best price exemptions under the drug rebate program (see S. 1195), S7476 [5JN] (see H.R. 2409), H5173 [10JN]

———require States that provide prescription drug coverage to cover drugs that treat obesity (see H.R. 2024), H3761 [7MY]

Medicare: assure that enrollment in any prescription drug program is voluntary (see H.R. 635), H322 [5FE]

———coverage of certain drugs and biologicals under the prospective payment system for hospital outpatient services (see S. 1206), S7540 [9JN]

———coverage of certain self-administered intramuscular and subcutaneous drugs (see H.R. 1956), H3681 [6MY]

———coverage of drugs and biologicals (see H.R. 194), H58 [7JA] (see H.R. 1032), H1464 [27FE]

———coverage of home infusion drug therapies (see H.R. 2476), H5407 [16JN]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant (see S. 178), S1068 [16JA] (see H.R. 2223), H4734 [22MY]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant without regard to when the transplant was received (see H.R. 588), H320 [5FE]

———coverage of immunosuppressive drugs for kidney transplant patients (see S. 191), S1069 [16JA]

———coverage of infertility treatment services for certain disabled individuals (see H.R. 969), H1461 [27FE]

———coverage of medication therapy management services (see S. 1270), S7926 [16JN]

———coverage of oral anticancer drugs (see S. 1037), S5995 [9MY] (see H.R. 1288), H1901 [13MR]

———coverage of oral drugs to treat low blood calcium levels or elevated parathyroid hormone levels for patients with end stage renal disease (see H.R. 128), H56 [7JA]

———coverage of outpatient prescription drugs (see S. 7), S34 [7JA] (see H.R. 38), H53 [7JA] (see H.R. 1045), H1470 [3MR] (see H.R. 1568), H2702 [2AP] (see H.R. 2461), H5365 [12JN] (see H.R. 2498), H5467 [17JN] (see H.R. 3299), H9477 [15OC]

———deliver a meaningful benefit and lower prescription drug prices (see S. 1950), S15812 [24NO]

———eliminate privatization, improve prescription drug benefit, and repeal health savings accounts (see S. 1992), S16120 [9DE]

———establish a prescription drug discount card endorsement program (see H.R. 513), H268 [31JA]

———establish a safety net outpatient prescription drug program for certain indigent beneficiaries (see H.R. 3332), H9687 [17OC]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (see H.R. 1199), H1744 [11MR]

———establish voluntary outpatient prescription drug discount and security program (see S. 778), S4823 [3AP] (see H.R. 2578), H5813 [24JN]

———expand coverage of certain self-injected biologicals (see S. 465), S2919 [27FE] (see H.R. 980), H1461 [27FE]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries (see H.R. 3671), H12918 [8DE]

———promote research for health promotion and disease prevention and add preventive benefits (see H.R. 1860), H3451 [29AP]

———provide beneficiaries with access to prescription drugs at Federal Supply Schedule prices (see H.R. 634), H322 [5FE]

———provide for negotiation of fair prices for prescription drugs (see S. 1994, 1999), S16120 [9DE] (see H.R. 3672), H12918 [8DE]

———provide prescription drug coverage and make improvements in payment for rural providers (see H.R. 2606), H5928 [25JN]

———reductions in prescription drug prices (see S. 891, 892), S5342 [11AP] (see H.R. 1400), H2269 [20MR]

———reductions in prescription drug prices for beneficiaries and women with breast cancer (see H.R. 896), H1332 [25FE]

———reform and provide prescription drug coverage (see S. 1), S7718 [11JN] (see H.R. 1), H5928 [25JN] (see H.R. 2473), H5407 [16JN]

———reform and provide prescription drug coverage (H.R. 1), consideration (see H. Res. 299), H5928 [25JN]

———reform and provide prescription drug coverage (H.R. 1), consideration of conference report (see H. Res. 463), H12306 [21NO]

———reform and provide prescription drug coverage (H.R. 1), consideration of conference report (H. Res. 463)—same-day consideration (see H. Res. 459), H11700 [20NO]

———reform payment method for covered drugs, drug administration services, and chemotherapy support services (see H.R. 1622), H2820 [3AP]

———reform reimbursement rates for chemotherapy drugs and administration (see S. 1303), S8300 [20JN]

———repeal Medicare Advantage Regional Plan Stabilization Fund (see S. 1995), S16120 [9DE]

———revise methodology by which payment for orphan drugs and biologicals is made under program prospective payment system for hospital outpatient department services (see H.R. 2700), H6602 [10JY]

Medicare Prescription Drug, Improvement, and Modernization Act: improve (see S. 1974), S15975 [25NO]

Members of Congress: provide that prescription drug coverage under a Federal health benefits plan not exceed the level of coverage under Medicare (see H.R. 2817), H7329 [22JY]

Mental health: protect children and their parents from being coerced into administering controlled substances in order to attend school (see S. 1390), S9244 [10JY] (see H.R. 2089), H4130 [14MY]

———protect children and their parents from being coerced into administering psychotropic medication in order to attend school (see H.R. 1170), H1743 [11MR]

National Guard: authorize the operation of counterdrug schools (see S. 1785), S13209 [24OC]

National Organization for Rare Disorders: anniversary (see H. Con. Res. 147), H3304 [10AP]

National Vaccine Injury Compensation Program: amend (see H.R. 1349), H2131 [19MR]

———include hepatitis A vaccines (see S. 814), S4957 [8AP]

———include influenza vaccines (see S. 1817), S13909 [4NO]

———repeal certain amendments (see H.R. 237), H134 [8JA]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (see S. 285), S1871 [4FE]

Office of National Drug Control Policy: reauthorize (see S. 1860), S14804 [12NO] (see H.R. 2086), H4129 [14MY]

Orphan Drug Act: anniversary (see H. Con. Res. 147), H3304 [10AP]

Pharmaceuticals: eligibility of certain applicants for approval of a generic drug for a competition-free period (see H.R. 828), H702 [13FE]

———establish therapeutic equivalence requirements for generic drugs (see H.R. 3401), H10129 [29OC]

———expand human clinical trials qualifying for the orphan drug tax credit (see H.R. 2931), H7782 [25JY]

———impact of illegal importation of prescription drugs on regulatory protections afforded consumers (see H. Con. Res. 225), H5663 [19JN]

———permit commercial importation of prescription drugs from Canada (see H.R. 847), H703 [13FE] (see H.R. 2497), H5467 [17JN] (see H.R. 2769), H7085 [17JY]

———permit importation of prescription drugs from Canada and Mexico (see H.R. 2629), H6262 [26JN]

———provide access and choice for use of generic drugs under Federal health care programs (see S. 51), S36 [7JA]

———provide for prices that are fair to the producer and the consumer (see H.R. 608), H321 [5FE]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 616), H321 [5FE]

———require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with promotional or marketing activities (see S. 948), S5484 [29AP] (see H.R. 757), H698 [13FE]

Prescription drugs: distribution chain (see H.R. 2232), H4735 [22MY]

Public Health Service Act: protection of human subjects in research (see H.R. 3594), H12307 [21NO]

Senior citizens: modify the eligibility criteria for supplemental foods provided under the Commodity Supplemental Food Program (see S. 468), S2919 [27FE] (see H.R. 1021), H1463 [27FE]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (see S. 614), S3730 [13MR]

Sports: encourage major sports organizations to ban use of ephedra and dietary supplements containing ephedrine (see H. Con. Res. 52), H1333 [25FE]

———prohibit gambling on high school and college sports and the Olympics and establish NIST grant program to fund detection and prevention of the use of performance-enhancing drugs (see S. 1002), S5771 [6MY]

Steroids: clarify definition of anabolic steroids, review sentencing guidelines for crimes involving steroids, and establish education programs relative to steroids (see S. 1780), S13134 [23OC]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 198), H58 [7JA]

———allow designation of income tax refunds for use in NIH biomedical research programs (see H.R. 1352), H2131 [19MR]

———allow drug manufacturers a tax credit if they certify that the price of a drug in the U.S. is not greater than its price in Canada or Mexico (see H.R. 354), H170 [27JA]

———allow Medicare beneficiaries a refundable credit for purchase of outpatient prescription drugs (see S. 142), S230 [13JA] (see S. 951), S5541 [30AP]

———apply excise tax to hepatitis A vaccines (see H.R. 1674), H2938 [8AP]

———disallow deductions and credits for companies who discriminate against Canadian pharmacies that pass along discounts to consumers living in the U.S. (see S. 477), S2920 [27FE]

———repeal the medicine and drugs limitation on the deduction for medical care (see H.R. 3596), H12307 [21NO]

———treatment of direct-to-consumer advertisements of prescription drugs (see H.R. 149), H57 [7JA]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (see H.R. 3155), H8490 [23SE]

———treatment of foods and supplements for dietary use, and medical foods as medical expenses (see H.R. 2627), H6262 [26JN]

Terrorism: provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (see S. 666), S3993 [19MR]

Tobacco products: eliminate quotas and price supports, compensate quota holders and producers, establish Tobacco Quality Board, assess user fees, and grant FDA authority to regulate tobacco (see H.R. 140), H56 [7JA]

Women: expand research for women in trauma (see S. 1811), S13711 [31OC]

———improve treatment for mental health and substance abuse needs of women with histories of trauma, including domestic and sexual violence (see S. 1810), S13711 [31OC]

Cloture motions

Medicare: reform and provide prescription drug coverage (H.R. 1), conference report, S15561 [22NO], S15698 [24NO]

Conference reports

Medicare Prescription Drug, Improvement, and Modernization Act (H.R. 1), H11877-H12103 [20NO]

Descriptions

Marinol (Dronabinol) Capsules, H7308 [22JY]

Explanations

Changes in Conference Report on H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act, Relative to Payment System for Cancer Drugs, S15887 [25NO]

Factsheets

Animal Drug User Fee Act Performance Goals and Procedures: FDA Center for Veterinary Medicine, S14791 [12NO]

Letters

Allow Medicare beneficiaries enrolled in fallback plans to remain in such plans for two years by regulating contracting cycles: James Firman, National Council on the Aging, S8394 [24JN]

Andean Counterdrug Initiative: Representatives Tom Davis and Souder, Committee on Government Reform (House), H2767 [3AP]

Animal Drug User Fee Act: Tommy G. Thompson, Sec. of HHS, S14791 [12NO]

Campus Classmate Offenders in Rehabilitation and Treatment (CORT) Act: Karen Freeman-Wilson, National Association of Drug Court Professionals, S2474 [13FE]

Clarify status of Medicare as a secondary payor: William E. Moschella, Dept. of Justice, S8276 [20JN]

Collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries: Gail E. Shearer, Consumers Union (organization), S8420 [24JN]

———Ronald F. Pollack, Families USA (organization), S8421 [24JN]

———RxHealthValue (organization), S8420 [24JN]

Dept. of HHS certification of safety and cost savings relative to commercial importation of prescription drugs from Canada: Asa Hutchinson, DEA, S8206 [19JN]

———Donna E. Shalala, S8204 [19JN]

———Mark B. McClellan, FDA, S8203, S8205 [19JN]

———Tommy G. Thompson, Sec. of HHS, S8204 [19JN]

Employer-sponsored retiree prescription drug coverage plans: several labor unions, S8411 [24JN]

Ensure Federal Employees Health Benefits Program prescription drug coverage for Medicare-eligible enrollees is actuarially equal to general enrollees: Charles L. Fallis, National Association of Retired Federal Employees, S8331 [23JN]

———Colleen M. Kelley, National Treasury Employees Union, S8331 [23JN]

Ensure that dual-eligible beneficiaries are eligible for Medicare prescription drug coverage: Paul Baldwin, Long Term Care Pharmacy Alliance, S8640 [26JN]

Expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis: Jodi L. Jacobson, Center for Health and Gender Equity, S9555 [17JY]

———Joseph F. O'Neill, Dept. of State, S12772 [17OC]

———Joseph F. O'Neill, Office of National AIDS Policy, S9549 [17JY]

———Leonard S. Rubenstein, Physicians for Human Rights (organization), S9555 [17JY]

———Linda Bales, General Board of Church & Society of the United Methodist Church, S9555 [17JY]

———Maureen T. Shea and Jere Myrick Skipper, Episcopal Church, S9554 [17JY]

———Paul Zeitz, Global AIDS Alliance, S9554 [17JY]

FDA review of marketing and classification of the painkiller OxyContin for treatment of moderate pain: Representative Wolf, E2435, E2436 [23NO]

———Representative Wolf, Committee on Appropriations (House), E1245 [13JN], E2434 [23NO]

FDA withdrawal of approved application for the drug known as RU-486 and review approval process: Monty and Helen Patterson, S15474 [21NO]

Greater access to affordable pharmaceuticals: Business for Affordable Medicine (organization), H6121 [26JN]

Guarantee option of Medicare provided prescription drug coverage for all beneficiaries: Barbara B. Kennelly, National Committee To Preserve Social Security and Medicare, S8091 [18JN]

Implementation of State laws relative to the use of marijuana for medicinal purposes: Chuck Canterbury, Fraternal Order of Police, H7303 [22JY]

———Ronald R. Brooks, National Narcotic Officers' Associations Coalition, H7303 [22JY]

Improve access to HIV/AIDS-related treatments and services in developing countries: Joseph F. O'Neill, Executive Office of the President, S11223 [9SE]

Include certain Caribbean nations in expansion of assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis: several ambassadors, S6483 [15MY]

Include educational information about prescription drugs in direct-to-consumer advertising: several health organizations, S8609 [26JN]

Increase awareness of autism spectrum disorder, support programs for research, and improve treatment: James W. Coll, H3536-H3538 [30AP]

International HIV/AIDS pandemic: Congressional Black Caucus, E409 [7MR]

Medicare alternative payment system for preferred provider organizations in highly competitive regions: Robert A. Sunshine, CBO, S8612 [26JN]

Medicare beneficiaries exemption from paying monthly premiums during any gap in coverage of their prescription drug benefit: Barbara B. Kennelly, National Committee To Preserve Social Security and Medicare, S8276 [20JN]

Medicare coverage of drug treatment therapy for HIV/AIDS patients: Tommy G. Thompson, Sec. of HHS, S15888 [25NO]

Medicare disease prevention services improvement: several former Secs. of HHS, E1424 [8JY]

Medicare drug plans and organizations transfer of savings from drug manufacturers' rebate, discount, and incentive programs to local pharmacies and consumers: Barry F. Scher and John J. Fegan, Ahold USA, Inc., S8183 [19JN]

———John J. Motley III, Food Marketing Institute, S8183 [19JN]

———Joseph A. Piohler, Kroger Co., S8184 [19JN]

———Randy Hutton, Winn Dixie Stores, Inc., S8184 [19JN]

Medicare Prescription Drug, Improvement, and Modernization Act: Edward G. Rendell, Governor of Pennsylvania, H12252 [21NO]

———Gary Locke, Tom Vilsack and Bill Richardson, Democratic Governors' Association, S15636 [23NO]

———Jeb Bush, Governor of Florida, H12243 [21NO]

———John Yoo, S15752-S15755 [24NO]

———Republican Governors Association, H12243 [21NO]

———several Members of Congress, S15536 [22NO]

———several Representatives, H12109, H12184 [21NO]

———several Senators, S15536 [22NO], S15897 [25NO]

Medicare Prescription Drug and Modernization Act: Representative Thomas, Committee on Ways and Means (House), H6086 [26JN]

———Representative Tom Davis, Committee on Government Reform (House), H6086 [26JN]

———Richard McGraw, H6088 [26JN]

Medicare prescription drug benefit coverage gap: William D. Novelli, AARP, S8387 [24JN]

Medicare+Choice program: several Senators, S8526 [25JN]

National Vaccine Injury Compensation Program revisions: Melinda Clark, H2299 [25MR]

Permit commercial importation of prescription drugs from Canada: Thomas Huebner and M. Betrice Grause, Vermont Association of Hospitals and Health Systems, E2174 [30OC]

Permit Medicare+Choice plans that disproportionately serve special needs or frail, elderly beneficiaries to offer specialized Medicare Advantage plans: Eugene Scanzera, Kaiser Permanente (health maintenance organization), S8522 [25JN]

———Karen A. Bullock, Community Health Partnership, Inc., S8689 [26JN]

———Karen Musser, Elder Care of Dane County, WI, S8689 [26JN]

———Richard J. Bringewatt, Medicare Payment Coalition for Frail Beneficiaries, S8523 [25JN]

Pharmacy Education Aid Act: several pharmaceutical organizations and associations, S3896 [18MR]

Prescription Drug and Medicare Improvement Act: Gail E. Shearer, Consumers Union, S8615 [26JN]

———George E. Pataki, Governor of New York, S8271 [20JN], S8856 [27JN]

Prohibit a health plan from contracting with a pharmacy benefit manager (PBM) unless certain requirements are satisfied: Charles Bofferding, Society of Professional Engineering Employees in Aerospace, S8616 [26JN]

———Charles M. Loveless, American Federation of State, County and Municipal Employees, S8616 [26JN]

———Rod Shafer, Washington State Pharmacy Association, S8616 [26JN]

———Ronald F. Pollack, Families USA (organization), S8616 [26JN]

Prohibit operation or provision of any place for the purpose of manufacturing, distributing, or using any controlled substance: David S. Germroth, Coalition of Licensed Beverage Associations, S1679 [28JA]

Religious organizations' campaign opposing drug reimportation reform legislation due to increased accessibility to abortion drug known as RU-486: Representatives Pitts and Chris Smith, H6997 [16JY]

———Tom Coburn, H6593 [10JY], H6997 [16JY]

Safety of vaccines containing mercury and thimerosal: Representative Burton, E1981 [7OC]

Smallpox Emergency Personnel Protection Act: Andrew L. Stern, Service Employees International Union, H2484 [31MR]

———Barry Kasinitz, International Association of Fire Fighters, H2483 [31MR]

———Charles M. Loveless, American Federation of State, County and Municipal Employees, H2484 [31MR]

———Charlotte Fraas, American Federation of Teachers, H2487 [31MR]

———Dennis Slocumb, International Union of Police Associations, H2487 [31MR]

———George C. Benjamin, American Public Health Association, H2487 [31MR]

———Rose Gonzalez, American Nurses Association, H2482 [31MR]

———W. Michael Scheld, Infectious Diseases Society of America, H2482 [31MR]

State grants for smallpox and other bioterrorism inoculation activities: Charles M. Loveless, American Federation of State, County and Municipal Employees, S4744 [3AP]

———Patrick M. Libbey, National Association of County & City Health Officials, S4744 [3AP]

———Rose Gonzalez, American Nurses Association, S4744 [3AP]

Vaccines containing thimerosal: Mark B. McClellan, FDA, H8259 [16SE]

Veterans Prescription Drug Benefits Act: Delatorro L. McNeal, Paralyzed Veterans of America (organization), E497 [18MR]

———Richard A. Jones, AMVETS (organization), E497 [18MR]

———Richard F. Weidman, Vietnam Veterans of America, Inc., E498 [18MR]

———Steve A. Robertson, American Legion, E497 [18MR]

———Thomas H. Miller, Blinded Veterans Association, E497 [18MR]

———William A. Wroolie, Military Order of the Purple Heart of the U.S.A., Inc., E497 [18MR]

Lists

Counterfeit prescription drugs, H7597 [24JY]

Organizations opposed to H.R. 1, Medicare Prescription Drug and Modernization Act, S15038 [18NO]

Pharmaceutical industry contributions to political parties, H6455 [9JY]

Senate and House staff members who contributed to H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act, S15914 [25NO]

Votes on point of order against Greater Access to Affordable Pharmaceuticals Act (2002), S15702 [24NO]

Memorandums

Reduce Disparity in Penalties for Crack and Powder Cocaine Offenses and Focus Drug Sentencing on Seriousness of Offense and Culpability of Offender: Margaret Simmons, S10602 [31JY]

Messages

Federal Drug and Substance Abuse Programs Review: President Bush, S7828 [12JN], H5345 [12JN]

National Drug Control Strategy: President Bush, S2338 [12FE], H435 [12FE]

National Emergency Relative to Narcotics Traffickers in Colombia: President Bush, S12837 [17OC], H9680 [17OC]

Plan Colombia Funding Report: President Bush, S1868 [4FE], H271 [4FE], H7319 [22JY]

Motions

Dept. of HHS: promulgate regulations for the reimportation of prescription drugs (H.R. 2427), H7610 [24JY]

Diseases: expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), S6450, S6500 [15MY], H4375 [21MY]

Medicare: reform and provide prescription drug coverage (H.R. 1), H6181 [26JN], H6658 [14JY], H8063 [9SE], H8182 [10SE], H8257 [16SE], H8361 [17SE], H8467 [23SE], H8879, H8880 [24SE], H8925 [25SE], H8996 [30SE], H9062 [1OC], H9171, H9180 [2OC], H9252 [7OC], H9349 [8OC], H9708 [20OC], H9780 [21OC], H9967 [28OC], H10083 [29OC], H10314 [4NO], H10428, H10438 [5NO], H10528 [6NO], H11186 [17NO], H11395, H11493 [18NO], H11598 [19NO], H11845 [20NO]

———reform and provide prescription drug coverage (H.R. 1), conference report, S15698 [24NO], H12294 [21NO]

———reform and provide prescription drug coverage (H.R. 1), motion to instruct conferees, H10106 [29OC]

———reform and provide prescription drug coverage (S. 1), S8343 [23JN], S8402, S8403, S8404, S8409 [24JN], S8609, S8622, S8636 [26JN]

Press releases

AARP Endorses Medicare Prescription Drug Bill: AARP, H11498 [18NO]

Medicare Prescription Drug, Improvement, and Modernization Act (H.R. 1): Iowa Hospital Association, S15580 [22NO]

Vermont Physicians and Hospitals Strongly Support Passage of Medicare Reform Legislation: Vermont Medical Society, Vermont Association of Hospitals and Health Systems, and Fletcher Allen Health Care, Inc., S15694 [24NO]

Proposals

Treatment of biological products and generic drugs relative to patent challenges and exclusivity rules, S16106 [9DE]

Questions and answers

Access to HIV/AIDS drugs under H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act: Senator Feinstein and Tommy G. Thompson, Sec. of HHS, S15597 [23NO]

Remarks in House

AARP: alleged conflict of interest relative to endorsement of Medicare reform and prescription drug coverage, H11494-H11496, H11498 [18NO], H11520 [19NO], H12253 [21NO]

———decision to support Medicare reform legislation, H11635, H11638 [19NO]

Amtrak: funding, H7885-H7887 [4SE]

Asthma Awareness Day: observance, H3647 [6MY]

Becton, Dickinson and Co.: tribute to efforts to combat the HIV/AIDS pandemic in Africa, E2404 [22NO]

Bush, President: evaluation of administration, H6873 [16JY]

Business and industry: investigate alleged pharmaceutical industry support of religious organizations' campaign opposing drug reimportation reform legislation due to increased accessibility to abortion drug known as RU-486, H6593 [10JY], H6682-H6685 [14JY], H6873, H6996 [16JY]

Caron Foundation: tribute, E1961 [2OC]

Catholic Church: tribute to efforts to combat drug abuse, E2344 [20NO]

Child Survival and Health Programs Fund: funding through reductions in Andean Counterdrug Initiative funding, H7394-H7402 [23JY]

Children and youth: impact of cultural changes and influences, H5167-H5171 [10JN]

———importance of international children's health programs, E873 [6MY]

Colombia: counternarcotics and counterterrorism activities funding, H2447 [27MR], H2734 [3AP]

———human rights violations, H8192 [10SE]

———U.S. policy, H6332-H6339 [8JY]

Congress: accomplishments, H9690 [20OC]

———accomplishments of the 108th Congress, H6873 [16JY], H7229 [22JY]

Consumers: correct impediments to allowing importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use, H8002 [5SE]

———discrepancy in prescription drug prices between U.S. and foreign countries, H4095 [14MY], H4342-H4349 [20MY], H4845 [3JN], H4953 [4JN], H5056-H5058 [9JN], H5155-H5159 [10JN], H5346, H5360-H5362 [12JN], H5453-H5459 [17JN], H6434 [9JY], H6858-H6864 [15JY], H9257 [7OC]

———establish fairer pricing for prescription drugs for individuals without access to discounted prices (H.R. 1694), H5697, H5698 [23JN]

Crime: foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (H.R. 2387), E1161 [5JN]

———respond to the illegal production, distribution, and use of methamphetamines, H7252 [22JY]

———respond to the illegal production, distribution, and use of methamphetamines (H.R. 834), E246 [13FE]

Dept. of Defense: eliminate authority to transfer certain funds in supplemental appropriations for ongoing military operations and reconstruction efforts in Iraq and Afghanistan, H9591, H9592 [16OC]

Dept. of HHS: establish Office of Correctional Health (H.R. 1993), E877 [6MY]

———give grant preference to States that require schools to allow students to self-administer medication for asthma or anaphylaxis (H.R. 2023), H3647 [6MY]

———promulgate regulations for the reimportation of prescription drugs, H9354 [8OC], H9969 [28OC], H10539 [6NO], H11372-H11377, H11504, H11509-H11512 [18NO], H12106, H12111, H12178 [21NO], E2350 [20NO]

———promulgate regulations for the reimportation of prescription drugs (H.R. 2427), H5247 [11JN], H5453-H5459 [17JN], H6583, H6592-H6595 [10JY], H6682-H6685 [14JY], H6858-H6864 [15JY], H6873, H6996 [16JY], H7198, H7200, H7202 [21JY], H7457, H7458, H7459, H7595-H7611 [24JY], H7813 [3SE], H8261 [16SE], H9465 [15OC], E1617, E1621, E1622, E1642, E1647, E1648, E1658, E1659 [25JY]

———promulgate regulations for the reimportation of prescription drugs (H.R. 2427), consideration (H. Res. 335), H7531-H7541 [24JY]

———promulgate regulations for the reimportation of prescription drugs (H.R. 2427), motion to recommit, H7610 [24JY]

———take action to remove dietary supplements containing ephedrine alkaloids from the market (H. Res. 435), E2259 [6NO]

Dept. of Homeland Security: Office of Domestic Preparedness funding through reductions in Andean Counterdrug Initiative funding, H2764-H2769 [3AP]

Dept. of HUD: reauthorize the Public Housing Drug Elimination Program (H.R. 1981), E872 [6MY]

Dept. of Justice: Edward Byrne Memorial State and Local Law Enforcement Assistance Program funding, H7358 [23JY]

Dept. of Veterans Affairs: coverage of outpatient prescription drugs, H421 [12FE]

———dispense medications to veterans for prescriptions written by private practitioners and provide Medicare coverage to eligible veterans (H.R. 1309), E496 [18MR]

———increase the quantity of supply of certain prescriptions furnished to veterans with chronic conditions (H.R. 1921), E1175 [9JN]

———negotiated prices for prescription drugs, H11499 [18NO]

Diseases: address the international HIV/AIDS pandemic, H446 [12FE], H1623-H1630 [5MR], E409 [7MR]

———AIDS epidemic, E2353 [20NO]

———authorize assistance to combat HIV/AIDS pandemic in sub-Saharan Africa and the Caribbean (H.R. 1857), E794 [29AP]

———encourage countries seriously affected by HIV/AIDS, malaria, and tuberculosis to accept U.S. food assistance, H3603 [1MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, H330 [11FE], H6330 [8JY], H6437 [9JY], H7370-H7375, H7402 [23JY], H10364-H10367 [5NO], H12823 [8DE], E1460 [11JY], E2404 [22NO]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), H2280 [25MR], H3457 [30AP], H3574, H3579-H3618 [1MY], H6583 [10JY], H7386 [23JY], E876 [6MY], E886 [7MY], E923 [9MY], E1057 [22MY], E1068, E1084 [23MY], E2258 [6NO]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), Senate amendments, H4375-H4382 [21MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), consideration (H. Res. 210), H3575-H3578 [1MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), corrections in enrollment (S. Con. Res. 46), H4382 [21MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), corrections in enrollment (S. Con. Res. 46), unanimous-consent agreement, H4511 [21MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), unanimous-consent agreement, H4325 [20MY]

———expand assistance to countries seriously affected by HIV/AIDS through reductions in the Millennium Challenge Account, H7383-H7393 [23JY]

———funding preference to programs operating in developing countries emphasizing prevention of HIV mother-to-child transmission and lifelong care for children of HIV/AIDS infected individuals, H4378 [21MY]

———improve access to HIV/AIDS-related treatments and services in developing countries, H9200 [2OC], H9650 [17OC]

———include certain Caribbean nations in expansion of assistance to countries seriously affected by HIV/AIDS, H6821, H6822 [15JY]

———protect health of individuals receiving smallpox vaccine and provide compensation to and access to care for individuals sustaining injury as a result of smallpox vaccination (H.R. 865), E267, E268 [13FE]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (H.R. 1413), H2300 [25MR]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (H.R. 1463), H2476, H2478-H2494 [31MR], E638 [1AP], E677 [3AP]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (H.R. 1770), H3339, H3340 [11AP], E795 [29AP]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (H.R. 1770), corrections in engrossment, H3343 [11AP]

———reduce first year's funding for assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, H3605-H3607 [1MY]

———require a certain percentage of assistance to countries seriously affected by HIV/AIDS be expended for HIV/AIDS orphans and vulnerable children, H3604, H3605 [1MY], H7402 [23JY]

———strengthen accountability and reporting requirements relative to assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, H3597-H3600 [1MY]

———urge Group of Eight members to pledge and contribute a substantial amount to the fight against HIV/AIDS, tuberculosis, and malaria (H. Con. Res. 180), E959 [15MY]

Drug abuse: national drug control policy, H435 [12FE], H3627-H3632 [1MY]

European Union: agreement to toughen and harmonize drug laws, H12884 [8DE]

FDA: campus construction funding, H7857 [4SE]

———lobbying activities relative to Pharmaceutical Market Access Act, H7459 [24JY]

———provide authority to require certain research into drugs used in pediatric patients (S. 650), H11567-H11572 [19NO]

———provide greater access to affordable pharmaceuticals, H2313 [26MR]

———remove the abortion drug known as RU-486 from market and review approval process, H10459 [6NO]

———review marketing of the painkiller OxyContin and its classification for treatment of moderate pain, E1245 [13JN], E2434 [23NO]

Federal aid programs: collect and assess scientific evidence regarding prescription drugs frequently used in federally funded health programs, H6560, H6561 [10JY]

Federal Employees Health Benefits Program: ensure prescription drug coverage for Medicare-eligible enrollees is actuarially equal to benefit offered to general enrollees (H.R. 2631), H6273, H6303-H6309 [8JY], E1411 [8JY], E1428, E1436 [9JY], E1446 [11JY]

Federal Food, Drug, and Cosmetic Act: amend relative to dietary supplements (H.R. 3377), E2150 [28OC], E2192 [31OC]

———amend relative to new animal drugs (H.R. 2079), E940 [13MY]

———establish a program of fees relative to animal drugs (H.R. 1260), H9054-H9059 [1OC], E462 [13MR]

———establish a program of fees relative to animal drugs (S. 313), H10293-H10297 [4NO]

———establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors (H.R. 725), E218 [13FE]

———establish requirements to allow sale of prescription drugs over the Internet (H.R. 2652), E1617 [25JY]

———require manufacturers of dietary supplements to register and require submission of reports on adverse experiences regarding such supplements (H.R. 724), E218 [13FE]

Florence, AL: anniversary of Milner-Rushing Discount Drugs (business), E808 [30AP]

Foreign aid: authorizing appropriations for foreign assistance programs, H6766-H6772 [15JY]

Garcia, Jose: Robert Wood Johnson Foundation Community Health Leadership Award recipient, E1192 [10JN]

Gary, IN: anniversary of Serenity House alcohol and drug treatment facility, E840 [1MY]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, H3585 [1MY]

———initiate campaign to increase public awareness and encourage private contributions, H3601, H3602 [1MY]

———limit top salary levels of administrators to that of the Vice President of the U.S., H3602 [1MY]

Gretick, Caroline: ATHENA award recipient, E84 [28JA]

Hazardous substances: provide assistance for poison prevention and stabilize funding of regional poison control centers (S. 686), H11574-H11577 [19NO], E2446 [23NO]

Health: improve patient safety and reduce incidence of medical errors (H.R. 663), H1766-H1774 [12MR]

———national policy to provide health care and reform insurance procedures, H162 [27JA], H2208, H2210 [20MR], H8961, H9025 [30SE]

———prohibit funds to prevent implementation of State laws relative to the use of marijuana for medicinal purposes, H7302-H7311 [22JY]

———safety of vaccines containing mercury and thimerosal, H9075 [1OC], E1981 [7OC]

———study link between child vaccinations and autism, H8258 [16SE], H9075 [1OC]

Health care professionals: establish an electronic system for practitioner monitoring of the dispensing of certain controlled substances (H.R. 3015), E1823 [17SE]

———implement an education loan repayment program for pharmacists (H.R. 3591), E2418 [22NO]

HIV Vaccine Awareness Day: observance, E970 [15MY]

Homeland Security Act: repeal certain provisions relative to pediatric vaccine manufacturer liability, H66, H119 [8JA], E89 [28JA], E113 [29JA], E164 [6FE]

House of Representatives: legislative priorities, H165 [27JA]

Houston, TX: tribute to Council on Alcohol and Drugs efforts to prevent substance abuse in youth, H2463 [27MR]

Immigration: impact of illegal immigration on the environment, H2918-H2922 [8AP]

———national policy, H2918-H2922 [8AP]

Individuals With Disabilities Education Act: ensure safe and drug-free learning environment for children with disabilities, H3525, H3526 [30AP]

Insurance: grant State high risk pool insurance programs reductions in prices charged for prescription drugs under Public Health Service Act prescription drug pricing agreements (H.R. 1291), E453 [13MR]

———require comprehensive coverage for childhood immunizations (H.R. 2095), E948 [14MY]

Korea, Democratic People's Republic of: participation in illegal drug trade to fund nuclear weapons programs, H6276 [8JY]

Law enforcement: ensure adequate funding is provided for certain high intensity drug trafficking areas, H8967 [30SE]

———ensure adequate funding is provided for certain high intensity drug trafficking areas (H.R. 1599), H2837 [7AP]

———improve security at U.S. borders, H1607 [5MR], H2697-H2701 [2AP], H2918-H2922 [8AP], H3442-H3447 [29AP], H4195-H4201 [15MY], H4355-H4360 [20MY], H4513-H4518 [21MY], H4868-H4874 [3JN], H8895-H8898 [24SE]

Linder, Brittany: Longview, TX, Partners in Prevention (organization) Red Ribbon Week drug free essay contest winner, E299 [27FE]

———Longview Partners in Prevention (organization) essay contest winner, E147 [6FE]

Medicaid: require States that provide prescription drug coverage to cover drugs that treat obesity, E755 [11AP]

———require States that provide prescription drug coverage to cover drugs that treat obesity (H.R. 2024), E887 [7MY]

Medicare: allow negotiated pricing for prescription drugs, H5912 [25JN]

———coverage of cancer drugs and treatments, E1800 [16SE]

———coverage of drugs and biologicals (H.R. 194), E11 [8JA]

———coverage of outpatient prescription drugs, H1477, H1501-H1507 [4MR], H1802 [12MR], H2694 [2AP], H3688 [7MY], H4790 [3JN], H5091, H5157 [10JN], H5246 [11JN]

———coverage of outpatient prescription drugs (H.R. 1568), E1416 [8JY]

———coverage of outpatient prescription drugs (H.R. 3299), E2041 [15OC]

———earnings test for beneficiaries relative to prescription drug coverage, H9181-H9187 [2OC], H9219 [7OC]

———eliminate gap in coverage of prescription drug benefit relative to cancer drugs, H5959 [26JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 1199), H5542 [18JN], E431, E433, E444 [12MR]

———improve disease prevention services, E1424 [8JY]

———privatization, H160 [27JA], H239 [29JA], H4759 [2JN], H5915-H5921 [25JN], H8182-H8189 [10SE], H9780-H9784 [21OC], H10439-H10443 [5NO], H11600, H11603, H11643 [19NO], H12903, H12905 [8DE], E2250 [6NO]

———prohibit implementation of premium support system which would require competition with private insurance carriers in delivering basic services, H10106-H10112 [29OC], H10528-H10534 [6NO]

———reductions in prescription drug prices, H5916-H5921 [25JN], H11857 [20NO]

———reductions in prescription drug prices (H.R. 1400), H5698, H5700 [23JN]

———reform, H187 [28JA], H1313-H1318 [25FE], H5179 [11JN]

———reform and provide prescription drug coverage, H10347 [5NO]

———reform and provide prescription drug coverage (H.R. 1), H5820, H5821, H5822, H5903-H5922 [25JN], H5942, H5943, H6007-H6104, H6107-H6256 [26JN], H6273, H6304-H6309 [8JY], H6438, H6448-H6455 [9JY], H6585 [10JY], H6658, H6685, H6700 [14JY], H7200 [21JY], H7234 [22JY], H7335 [23JY], H7792, H7812, H7813 [3SE], H8021 [9SE], H8262 [16SE], H9001 [30SE], H9219 [7OC], H9354 [8OC], H9488 [16OC], H9972 [28OC], H10159, H10160 [30OC], H10316, H10318 [4NO], H10347 [5NO], H11122 [7NO], H11191-H11199 [17NO], H11365, H11367, H11368, H11504, H11509-H11512 [18NO], H11518-H11520, H11629, H11634-H11647 [19NO], H11658, H11659, H11660, H11661, H11856-H11858, H11860, H11862, H11868-H11874 [20NO], E1411, E1415, E1416, E1419, E1422 [8JY], E1489, E1490 [15JY], E1642 [25JY], E1800 [16SE], E1956 [2OC]

———reform and provide prescription drug coverage (H.R. 1), conference report, H11362 [18NO], H12106, H12107, H12108-H12113, H12184, H12185, H12247-H12297 [21NO], H12750, H12752, H12761, H12846-H12854, H12879, H12883, H12901-H12908 [8DE], E2455 [25NO], E2474 [8DE]

———reform and provide prescription drug coverage (H.R. 1), conference report—unanimous-consent agreement, H12239 [21NO]

———reform and provide prescription drug coverage (H.R. 1), consideration (H. Res. 299), H5948, H5949, H5952-H5973 [26JN]

———reform and provide prescription drug coverage (H.R. 1), consideration of conference report (H. Res. 463), H12230-H12246 [21NO]

———reform and provide prescription drug coverage (H.R. 1), consideration of conference report (H. Res. 463)—same-day consideration (H. Res. 459), H12174-H12181 [21NO]

———reform and provide prescription drug coverage (H.R. 1), motion to instruct conferees, H6658-H6666 [14JY], H8182-H8189 [10SE], H8361-H8365 [17SE], H8879, H8880-H8887 [24SE], H8925-H8930 [25SE], H9062-H9067 [1OC], H9171-H9187 [2OC], H9349-H9354 [8OC], H9780-H9784 [21OC], H10106-H10112 [29OC], H10438-H10443 [5NO], H10528-H10534 [6NO], H11493-H11500 [18NO], H11598-H11605 [19NO], H11845-H11853 [20NO], E1907 [25SE], E1968 [2OC], E2013 [8OC], E2250 [6NO]

———reform and provide prescription drug coverage (H.R. 1), motion to recommit, H6254, H6255 [26JN]

———reform and provide prescription drug coverage (H.R. 2473), H5386-H5388, H5392-H5405 [16JN], H5415, H5417, H5446, H5449-H5451, H5453 [17JN], H5473, H5474, H5542-H5549 [18JN], H5553, H5555, H5639-H5642 [19JN], H5688, H5690-H5701 [23JN], H5717, H5718, H5719, H5720, H5796, H5799-H5808 [24JN], E1671 [3SE]

———reform payment method for covered drugs, drug administration services, and chemotherapy support services (H.R. 1622), H5802 [24JN]

———treatment of women, H5904, H5909, H5911 [25JN], H5954-H5956, H5959, H5961, H5962, H6109 [26JN]

Members of Congress: provide that prescription drug coverage under a Federal health benefits plan not exceed the level of coverage under Medicare, E1490 [15JY]

Mental health: protect children and their parents from being coerced into administering psychotropic medication in order to attend school, H3457 [30AP]

———protect children and their parents from being coerced into administering psychotropic medication in order to attend school (H.R. 1170), H1753 [12MR], H4382-H4387 [21MY], E432 [12MR]

Monical Pizza Corp.: Drug Abuse Resistance Education (D.A.R.E.) Program Restaurant Neighbor Award finalist, E2498 [8DE]

Morality and ethics: impact of social ills on society, H9732-H9737 [20OC]

National Organization for Rare Disorders: anniversary (H. Con. Res. 147), H4215-H4217 [19MY], E1000 [21MY]

National security: ensure that unapproved medical products made available during a declared emergency are returned to unapproved status following termination of declared emergency, H6928 [16JY]

National Vaccine Injury Compensation Program: repeal certain amendments (H.R. 237), H1779 [12MR], H1925 [18MR], H2100 [19MR], H2299 [25MR], H2913, H2914 [8AP], H3535 [30AP]

New Jersey: impact of Medicare legislation on Pharmaceutical Assistance to the Aged & Disabled (PAAD) program, H12262 [21NO]

NIH: biomedical research funding, H6517-H6521 [10JY]

Office of National Drug Control Policy: reauthorize (H.R. 2086), H8962-H8972 [30SE]

Older Americans Act: funding, H6521 [10JY]

Orphan Drug Act: anniversary (H. Con. Res. 147), H4215 [19MY], E1000 [21MY]

Pharmaceuticals: improve safety and efficacy for children, H11570 [19NO]

———pediatric vaccine manufacturer liability protection, H1876 [13MR], H2299 [25MR], H2913, H2914 [8AP], H4220 [19MY]

———permit commercial importation of prescription drugs from Canada, H6620, H6700 [14JY], E1489 [15JY], E2174 [30OC]

———permit commercial importation of prescription drugs from Canada (H.R. 847), H4768 [2JN]

———permit importation of prescription drugs, H9709 [20OC]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 616), E190 [12FE]

———reductions in prescription drug prices, H2915 [8AP], H2942 [9AP], H3661 [6MY], H3834 [8MY], H3998 [13MY], H4095 [14MY], H4175 [15MY], H4763-H4770 [2JN], H4789 [3JN], H5039 [5JN], H5056-H5058 [9JN], H5155-H5159 [10JN], H5346, H5360-H5362 [12JN], H5446, H5447, H5453-H5459 [17JN], H5796, H5801 [24JN], H9253, H9254, H9257 [7OC], H9800 [21OC], H11196-H11198 [17NO], H12901-H12903, H12907 [8DE]

———require manufacturers to sell FDA-approved prescription drugs to U.S. wholesalers and retailers on the same terms as Canadian purchasers, H12752 [8DE]

———safety of imported prescription drugs, H5249 [11JN], H9253, H9254 [7OC], H9800 [21OC], H11599 [19NO]

Prison Fellowship (organization): tribute, H1697 [11MR]

Project 90, Inc.: tribute, E1889 [25SE]

Red Ribbon Week: support goals, H10136 [30OC]

Slaven-Emond, AliceMarie: Robert Wood Johnson Foundation Community Health Leadership Award recipient, E1192 [10JN]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (H.R. 198), H1693 [11MR]

———allow drug manufacturers a tax credit if they certify that the price of a drug in the U.S. is not greater than its price in Canada or Mexico (H.R. 354), amendment process, H675 [13FE]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (H.R. 3155), E1862 [23SE]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack, H2676 [2AP]

Truth Seekers Substance Outreach Ministry, Inc.: anniversary, E498 [18MR]

Tulia, TX: condemn drug arrests and convictions of African Americans based solely on the false testimony of a police officer, H4242 [19MY]

United Steelworkers of America: support for health care bill of rights, E1688 [4SE]

Veterans: disability benefits, H10982, H10987, H10989, H11122 [7NO]

———health care funding, H4852 [3JN], H5179 [11JN], H5355 [12JN], H9471, H9473, H9475 [15OC], H9518 [16OC], H10322 [4NO], H10460 [6NO]

WHYI-Radio (Miramar, FL): tribute to charity efforts for Here's Help, Inc., youth drug and alcohol treatment facility, H2941 [9AP]

Women: ensure that programs in countries seriously affected by HIV/AIDS include a curriculum for men and boys that emphasizes gender equality and respect for women and girls, H3600 [1MY]

Wyeth (company): tribute to Wyeth Pharmaceuticals patient assistance program, E1350 [25JN]

Remarks in Senate

AARP: alleged conflict of interest relative to endorsement of Medicare reform and prescription drug coverage, S15585 [22NO], S15729 [24NO]

Agency for Healthcare Research and Quality: collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries, S8419-S8421, S8422 [24JN], S8529, S8530 [25JN]

AIDS Drug Assistance Program: funding, S11228, S11229 [9SE], S11269 [10SE]

Andean Counterdrug Initiative: funding, S4818 [3AP]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs, S8012 [18JN], S8351 [23JN], S8429, S8431 [24JN], S8692 [26JN], S15884-S15886 [25NO]

———enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 946), S5493, S5494 [29AP]

Biological weapons: State grants for smallpox and other bioterrorism inoculation activities, S4742-S4747 [3AP]

Bush, President: State of the Union Message, S1500-S1509 [28JA], S1689-S1692, S1694-S1696 [29JA], S1765-S1770 [30JA]

Business and industry: permit biomedical research corporations to engage in certain equity financings without incurring limitations on net operating loss carryforwards and certain built-in losses (S. 1773), S13055 [22OC]

Centers for Disease Control and Prevention: HIV/AIDS blood safety and injection safety in Africa plan funding, S11362-S11364 [10SE]

———improve injection safety in immunization programs in developing countries, S6614 [19MY]

———National Immunization Program funding, S11231, S11232 [9SE], S11272 [10SE]

———Vaccines for Children Program funding, S11335, S11336 [10SE]

Colleges and universities: provide grants to States to establish partnerships among colleges and universities and surrounding communities to reduce underage and binge drinking and illicit drug use by students (S. 406), S2480 [13FE]

Colombia: anniversary of Plan Colombia, S9204 [10JY]

Committee on Finance (Senate): tribute to staff for efforts relative to S. 1, Prescription Drug and Medicare Improvement Act, S8700 [26JN]

Consumers: discrepancy in prescription drug prices between U.S. and foreign countries, S2793 [26FE]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans, S3423-S3428, S3468-S3478 [11MR], S3613 [12MR]

———require equitable coverage of drugs, devices, and services under health insurance plans (S. 1396), S9416 [15JY]

Correctional institutions: require minimum work week, job training, and life skills preparation for Federal prison inmates and establish a grant program for mandatory drug testing (S. 672), S4169 [20MR]

Courts: authorize grants for establishment of quasi-judicial campus drug courts at colleges and universities (S. 399), S2473 [13FE]

Crime: foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (S. 1194), S7483-S7488 [5JN], S13317-S13322 [27OC], S13373 [28OC]

———prohibit opening, maintaining, managing, controlling, renting, leasing, making available for use, or profiting from any place for the purpose of manufacturing, distributing, or using any controlled substance, S10606-S10608 [31JY]

———prohibit opening, maintaining, managing, controlling, renting, leasing, making available for use, or profiting from any place for the purpose of manufacturing, distributing, or using any controlled substance (S. 226), S1677-S1679 [28JA]

———reduce criminal gang activities (S. 1735), S12616-S12619 [15OC]

———respond to the illegal production, distribution, and use of methamphetamines, S4555 [31MR]

DEA: anniversary (S. Res. 263), S14274 [7NO]

Democratic Party: national agenda, S14638 [12NO]

Dept. of Defense: reevaluate necessity and safety of anthrax and smallpox vaccinations for troops (S. Res. 278), S16032-S16034 [25NO]

Dept. of HHS: certify safety and cost savings relative to commercial importation of prescription drugs from Canada, S8203-S8215 [19JN], S8266-S8268 [20JN]

———develop literacy standards for informational materials to assist in the safe and appropriate use of prescription drugs, S8422 [24JN]

———drug addiction treatment programs funding, S4371 [25MR]

———include educational information about prescription drugs in direct-to-consumer advertising, S8609 [26JN]

———promulgate regulations for the reimportation of prescription drugs, S15531 [22NO]

———promulgate regulations for the reimportation of prescription drugs (S. 1781), S13142, S13184 [23OC], S13187, S13207, S13229 [24OC]

———require drug companies to test drugs against their competitors, disclose results of such tests in advertising, and include educational information about the drug in direct-to-consumer advertising, S8484, S8485 [25JN]

Dept. of Veterans Affairs: permit Medicare-eligible veterans to receive an outpatient medication benefit (S. 1153), S7147-S7149 [23MY]

Detroit Neighborhood Services Organization: tribute to Youth Initiatives Project for efforts to combat drug use and gun violence, S1799 [30JA]

Diseases: address the international HIV/AIDS pandemic, S314 [15JA], S1793-S1797 [30JA], S1967 [5FE], S12715 [16OC]

———address the international HIV/AIDS pandemic (S. 250), S1814-S1816 [30JA]

———combat polio (S. Res. 109), S4974 [8AP]

———combat polio (S. Res. 266), S15303 [20NO]

———ensure access to assured quality pharmaceuticals at the lowest possible price to countries seriously affected by HIV/AIDS, S6478-S6480 [15MY]

———establish a comprehensive Federal effort relating to early detection of, treatments for, and prevention of cancer (S. 1101), S6864-S6867 [21MY]

———expand assistance to countries seriously affected by HIV/AIDS, S4409 [26MR]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, S314 [15JA], S1347-S1350 [22JA], S1464 [23JA], S8871 [7JY], S9100 [9JY], S9182-S9184, S9186-S9188, S9190, S9191 [10JY], S12667, S12668 [16OC], S12772 [17OC], S13190-S13192 [24OC], S13256-S13258 [27OC], S13347-S13349, S13368, S13371, S13419 [28OC], S13638-S13647 [30OC], S16083, S16084 [9DE]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), S5753 [6MY], S6036 [13MY], S6147, S6249 [14MY], S6415-S6421, S6445-S6450, S6475-S6500 [15MY], S6574, S6614 [19MY], S7119-S7121 [23MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), corrections in enrollment (S. Con. Res. 46), S6786 [20MY], S6918 [22MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (H.R. 1298), unanimous-consent agreement, S6196 [14MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (S. 1009), S5878 [7MY], S6416, S6417 [15MY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis through reductions in Dept. of Defense procurement, research, development, and evaluation funding, S9547-S9557 [17JY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis through reductions in Millennium Challenge Account, S13645-S13648 [30OC]

———HIV/AIDS blood safety and injection safety in Africa plan funding, S13346, S13347 [28OC]

———improve access to HIV/AIDS-related treatments and services in developing countries, S10963-S10966 [2SE], S11021-S11023 [3SE], S11076 [4SE], S11215, S11218-S11223, S11225 [9SE], S11300-S11302 [10SE], S11410 [11SE], S11712-S11715 [18SE]

———improve data collection and dissemination between Federal and State registries to enhance the treatment and research of cancer (S. 1899), S15289 [20NO]

———include certain Caribbean nations in expansion of assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, S6482-S6484 [15MY]

———international mother-to-child HIV/AIDS transmission prevention activities funding, S11102, S11105 [4SE], S11330, S11331 [10SE]

———provide benefits for certain individuals sustaining injury as a result of smallpox vaccination (H.R. 1770), S5388-S5390 [11AP]

———provide compensation to health care and emergency workers sustaining injury as a result of the smallpox vaccine, S1450 [23JA]

———require a certain percentage of assistance to countries seriously affected by HIV/AIDS be expended for HIV/AIDS orphans and vulnerable children, S6481, S6488 [15MY]

———require a certain percentage of assistance to countries seriously affected by HIV/AIDS be expended for women's health and empowerment programs and to reduce women's vulnerability to HIV/AIDS, S6485 [15MY]

———tuberculosis drug access funding, S13649 [30OC]

District of Columbia: needle exchange programs funding, S2420 [13FE]

FDA: provide authority to require certain research into drugs used in pediatric patients (S. 650), S3897 [18MR], S9811-S9819 [23JY]

———review safety of dietary supplements containing ephedrine, S14002 [5NO]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (S. 1930), S15473 [21NO]

Federal Employees Health Benefits Program: ensure prescription drug coverage for Medicare-eligible enrollees is actuarially equal to benefit offered to general enrollees, S8330 [23JN]

Federal Food, Drug, and Cosmetic Act: amend relative to new animal drugs (S. 741), S4530 [27MR]

———establish a program of fees relative to animal drugs (S. 313), S7165 [23MY], S7266 [3JN], S14279-S14282 [7NO], S14791 [12NO]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (S. 1460), S9968 [25JY]

———provide greater access to affordable pharmaceuticals, S1506 [28JA], S8187-S8198, S8200 [19JN], S8689-S8692 [26JN]

———provide greater access to affordable pharmaceuticals (S. 54), S58 [7JA], S7966 [17JN]

———provide greater access to affordable pharmaceuticals (S. 7), S134-S136 [9JA]

Foreign aid: authorizing appropriations for foreign assistance programs, S9087-S9111 [9JY], S9162-S9184, S9186-S9215 [10JY], S13352-S13356 [28OC]

Foreign policy: improve drug enforcement interdiction efforts, S14310 [10NO]

Foreign trade: combat piracy of intellectual property through international narcotics and law enforcement funding, S13649, S13650 [30OC]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, S6446-S6448, S6491, S6498 [15MY]

Government regulations: eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (S. 1784), S13146, S13147 [23OC]

———prohibit sales of products such as dietary supplements containing ephedra or ephedrine alkaloids, S2511-S2513 [14FE], S2674-S2676 [25FE]

Hazardous substances: poison control centers funding, S11101, S11105 [4SE]

———provide assistance for poison prevention and stabilize funding of regional poison control centers (S. 686), S4286 [21MR], S8316, S8317 [20JN], S16201 [9DE]

Health: efficacy of flu shots, S5531 [30AP]

———national policy to provide health care and reform insurance procedures, S214 [13JA]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (S. 1410), S9422 [15JY]

———provide compensation for injuries resulting from smallpox countermeasures, provide protection against chemical or radiological agents, increase distribution of vaccines, and improve vaccine injury compensation (S. 15), S5791 [6MY], S6572 [19MY]

———recognize recent breakthroughs in medical research and support continued efforts in disease prevention and cures, S8839-S8842 [27JN]

———require notification by manufacturers before discontinuing production of a vaccine and develop a national vaccine stockpile (S. 371), S2356-S2358 [12FE]

———suspend the Outcome and Assessment Information Set requirement for non-Medicare and non-Medicaid patients to reduce paperwork, S8608 [26JN]

Health care professionals: implement an education loan repayment program for pharmacists (S. 648), S3896, S3897 [18MR], S8106 [18JN], S16054 [25NO]

Homeland Security Act: repeal certain provisions relative to pediatric vaccine manufacturer liability, S1439 [23JA]

———repeal certain provisions relative to pediatric vaccine manufacturer liability (S. 105), S81 [7JA]

———repeal certain provisions (S. 41), S45-S47 [7JA]

Institute of Medicine: findings of report entitled ``Hidden Costs, Value Lost—Uninsurance in America'', S8277 [20JN]

Insurance: economic impact of undiagnosed and untreated illnesses, S8277 [20JN]

———prohibit a health plan from contracting with a pharmacy benefit manager (PBM) unless certain requirements are satisfied, S8613-S8617 [26JN]

———prohibit a health plan from contracting with a pharmacy benefit manager (PBM) unless certain requirements are satisfied (S. 1300), S8244 [19JN]

Iowa: methaphetamine reduction programs funding, S1407 [23JA]

Marin County, CA: anniversary of Marin Services for Women (organization), S7472 [5JN]

Medicaid: allow States to enter into drug rebate agreements to make prescription drugs available to individuals who are not otherwise eligible for medical assistance (S. 542), S3112 [5MR]

———clarify that inpatient drug prices charged to certain public hospitals are included in best price exemptions under the drug rebate program (S. 1195), S7488 [5JN]

———reform, S1958-S1960 [5FE]

Medicare: allow beneficiaries enrolled in fallback plans to remain in such plans for two years by regulating contracting cycles, S8285 [20JN], S8390-S8394, S8408 [24JN]

———allow certain beneficiaries to purchase supplemental Medigap prescription drug plans, S8641, S8648 [26JN]

———allow certain States to opt out of prescription drug coverage program, S8687 [26JN]

———allow personal contributions to participate private fee-for-service plans, S8687 [26JN]

———clarification of a hospital ``under development'' relative to exemption from the self-referral limitation, S15743 [24NO]

———coordination of benefits for prescription drug plans and State pharmaceutical assistance programs, S8653 [26JN]

———coverage of cancer drugs and treatments, S11305 [10SE], S15739, S15740 [24NO]

———coverage of certain drugs and biologicals under the prospective payment system for hospital outpatient services (S. 1206), S7543 [9JN]

———coverage of drug treatment therapy for HIV/AIDS patients, S15596 [23NO], S15887, S15888 [25NO]

———coverage of FDA-approved prescription drug therapies for beneficiaries with multiple sclerosis, S8546 [25JN]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant (S. 178), S1071 [16JA]

———coverage of immunosuppressive drugs for kidney transplant patients (S. 191), S1082 [16JA]

———coverage of medication therapy management services (S. 1270), S7931 [16JN]

———coverage of oral anticancer drugs (S. 1037), S6000, S6001 [9MY]

———coverage of outpatient prescription drugs, S1505, S1506 [28JA], S2047 [6FE], S2652 [25FE], S3050, S3052 [4MR], S3111 [5MR], S3974-S3979 [19MR], S4109, S4110 [20MR], S4265 [21MR], S4336 [25MR], S6214 [14MY], S6421, S6459, S6460 [15MY], S6641, S6642 [20MY], S7182-S7186 [2JN], S7270, S7272-S7274 [4JN]

———coverage of outpatient prescription drugs (S. 7), S134-S136 [9JA]

———coverage of syringes and medical supplies necessary for the administration of insulin, S8283 [20JN]

———definition of negotiated price for drug coverage relative to inclusion of dispensing fees, S15742, S15743 [24NO]

———eliminate gap in coverage of prescription drug benefit, S8387-S8389, S8392, S8393, S8403, S8404 [24JN]

———eliminate gap in coverage of prescription drug benefit relative to Alzheimer's disease drugs, S8624 [26JN]

———eliminate gap in coverage of prescription drug benefit relative to cancer drugs, S8481 [25JN], S8621, S8622 [26JN]

———eliminate privatization, improve prescription drug benefit, and repeal health savings accounts (S. 1992), S16127 [9DE]

———encourage availability of Medicare Advantage benefits in medically underserved areas, S8489-S8495 [25JN]

———ensure beneficiaries have convenient access to retail pharmacies for prescription drug coverage and prohibit the tying of contracts by health plans, S8487, S8488, S8489 [25JN], S15743 [24NO]

———ensure contributions for prescription drug coverage made by beneficiaries' former employers be treated as incurred costs, S8326, S8329 [23JN], S8394, S8410 [24JN]

———ensure that current retirees who are subject to lose prescription drug coverage will have the option of drug coverage under the Medicare fallback, S8660-S8662, S8701 [26JN]

———ensure that dual-eligible beneficiaries are eligible for prescription drug coverage, S8324-S8329 [23JN], S8393 [24JN], S8640, S8641, S8644, S8647 [26JN]

———establish permanent lifestyle modification program for beneficiaries, S8653 [26JN]

———establish voluntary outpatient prescription drug discount and security program, S8493 [25JN], S8663-S8675 [26JN]

———establish voluntary outpatient prescription drug discount and security program (S. 778), S4828 [3AP]

———evaluate alternative payment and delivery systems, S8539-S8545 [25JN], S8618-S8620, S8637, S8638 [26JN]

———exempt beneficiaries from paying monthly premiums during any gap in coverage of their prescription drug benefit, S8274-S8277 [20JN], S8486 [25JN]

———expand coverage of certain self-injected biologicals, S8346 [23JN], S8416-S8418 [24JN]

———expedite implementation of prescription drug coverage following enactment of reform legislation, S8349 [23JN], S8405-S8409 [24JN]

———guarantee option of Medicare provided prescription drug coverage for all beneficiaries, S8089-S8104, S8108 [18JN], S8657 [26JN]

———inclusion of disease management as a permanent part of the fee-for-service program, S8545 [25JN]

———income related increase in Medicare premium, S8680 [26JN]

———increase direct subsidy to employers retaining retiree prescription drug coverage plans, S8410-S8412 [24JN]

———increase the availability of discounted prescription drugs through grants to health centers, hospitals, and other qualifying institutions, to create in-house pharmacies, S8280 [20JN]

———limit premium increases, S8172-S8174, S8184-S8186, S8198-S8200 [19JN]

———limit the extent to which premiums and benefits of prescription drug coverage plans may vary, S8498-S8500 [25JN]

———lower premiums and improve coverage in prescription drug plans, S8625-S8632, S8637 [26JN]

———permit continuous open enrollment and disenrollment in prescription drug plans, S8401-S8403 [24JN]

———permit Medicare+Choice plans that disproportionately serve special needs or frail, elderly beneficiaries to offer specialized Medicare Advantage plans, S8522, S8523 [25JN], S8688 [26JN]

———provide additional assistance to beneficiaries with certain serious medical conditions during any gap in coverage of their prescription drug benefit, S8630-S8632, S8636 [26JN]

———provide beneficiaries with information on advance directives, S8652 [26JN]

———provide cost-sharing prescription drug coverage for certain beneficiaries in certain income categories, S8412-S8414 [24JN]

———provide for equitable reimbursement rates for Medicare Advantage prescription drug plans, S8346 [23JN]

———provide for income-related increase in part B premium for individuals and married couples with incomes exceeding a certain level, S8677, S8678 [26JN]

———provide for negotiation of fair prices for prescription drugs (S. 1994), S16133 [9DE]

———provide for negotiation of fair prices for prescription drugs (S. 1999), S16138 [9DE]

———provide that beneficiaries who remain in the fee-for-service program receive the same drug benefit as those enrolled in a private plan, S4120 [20MR]

———reductions in prescription drug prices, S8490-S8493 [25JN]

———reform and provide prescription drug coverage, S12436-S12438 [3OC]

———reform and provide prescription drug coverage (H.R.. 1), S9581, S9582 [17JY]

———reform and provide prescription drug coverage (H.R. 1), S8898 [7JY], S9295-S9298 [11JY], S10960, S10962 [2SE], S11073 [4SE], S11146, S11155 [5SE], S11305 [10SE], S12151 [30SE], S14925-S14927 [17NO], S15036-S15038, S15047-S15051 [18NO], S15110, S15147-S15149, S15167-S15170, S15172-S15175 [19NO]

———reform and provide prescription drug coverage (H.R. 1), conference report, S15362-S15368, S15373-S15376, S15379-S15385, S15399 [21NO], S15514, S15519, S15521-S15569, S15574-S15588 [22NO], S15592-S15644, S15663-S15667 [23NO], S15670-S15771 [24NO], S15882-S15902, S15904-S15915, S15918, S15919, S15927-S15932, S15950 [25NO], S16104-S16107 [9DE]

———reform and provide prescription drug coverage (H.R. 1), conference report—unanimous-consent agreement, S15510 [21NO], S15528 [22NO]

———reform and provide prescription drug coverage (H.R. 1), insert S. 1 language in lieu, S8898 [7JY]

———reform and provide prescription drug coverage (S. 1), S7563, S7564, S7572 [10JN], S7665-S7668 [11JN], S7905-S7922 [16JN], S7943-S7974 [17JN], S8012, S8013-S8116 [18JN], S8167, S8202-S8216 [19JN], S8265-S8295 [20JN], S8323-S8354 [23JN], S8386-S8398, S8400-S8431 [24JN], S8479-S8546 [25JN], S8605-S8633, S8635-S8645, S8647-S8709 [26JN], S8832, S8850-S8856 [27JN], S8870, S8871 [7JY], S12910 [21OC], S12992 [22OC], S13068 [23OC], S14084 [6NO], S14960 [17NO]

———reform and provide prescription drug coverage (S. 1), unanimous-consent agreement, S7868 [13JN], S8706 [26JN]

———reform and provide prescription drug coverage (S. 1), unanimous-consent request, S8411 [24JN], S8686 [26JN]

———reform reimbursement rates for chemotherapy drugs and administration, S15887 [25NO]

———reform reimbursement rates for chemotherapy drugs and administration (S. 1303), S8302 [20JN]

———repeal Medicare Advantage Regional Plan Stabilization Fund (S. 1995), S16133 [9DE]

———require drug plans and organizations to transfer savings from drug manufacturers' rebate, discount, and incentive programs to local pharmacies and consumers, S8105-S8108 [18JN], S8183, S8184 [19JN]

———streamline regulations, S8350 [23JN]

Medicare Prescription Drug, Improvement, and Modernization Act: improve (S. 1974), S16022 [25NO]

Medicare/Medicaid: improve services, S1389-S1392, S1402, S1403 [23JA]

Members of Congress: provide that prescription drug coverage under a Federal health benefits plan not exceed the level of coverage under Medicare, S8350 [23JN], S8408 [24JN]

National Bipartisan Commission on Medicare Reform: establish, S8514 [25JN]

National Guard: authorize the operation of counterdrug schools (S. 1785), S13210 [24OC]

National security: U.S.-Mexico vehicle barriers construction funding, S9785 [23JY]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 285), S1886 [4FE], S9819-S9823 [23JY]

NIH: children's health research funding, S11102 [4SE]

Office of National Drug Control Policy: reauthorize (S. 1860), S14811-S14815 [12NO]

Pharmaceuticals: permit commercial importation of prescription drugs from Canada, S8186, S8203-S8215 [19JN], S8265, S8269 [20JN]

———require manufacturers to sell FDA-approved prescription drugs to U.S. wholesalers and retailers on the same terms as Canadian purchasers, S8332-S8335, S8341-S8343 [23JN], S8403 [24JN]

———treatment of biological products and generic drugs relative to patent challenges and exclusivity rules, S16104-S16107 [9DE]

South Africa: implementation of Government-sponsored HIV/AIDS treatment programs, S15272 [20NO]

South America: reinstatement of policy allowing U.S. involvement in the interdiction of aircraft suspected of drug trafficking, S202 [10JA]

Sports: prohibit gambling on high school and college sports and the Olympics and establish NIST grant program to fund detection and prevention of the use of performance-enhancing drugs (S. 1002), S5784 [6MY], S5941 [8MY]

Steroids: clarify definition of anabolic steroids, review sentencing guidelines for crimes involving steroids, and establish education programs relative to steroids (S. 1780), S13139-S13142 [23OC]

Taxation: allow Medicare beneficiaries a refundable credit for purchase of outpatient prescription drugs (S. 951), S5597, S5598 [30AP]

———disallow deductions and credits for companies who discriminate against Canadian pharmacies that pass along discounts to consumers living in the U.S. (S. 477), S2935 [27FE]

———repeal dividend and top rate tax cuts and use savings for Medicare prescription drug program, S6437 [15MY]

Terrorism: provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (S. 666), S4009-S4016 [19MR], S4152 [20MR]

Reports

Impact of Republican Medicare Proposals on Insurance Industry Revenues and Profits: Committee on Health, Education, Labor, and Pensions (Senate) Minority Staff, S15769 [24NO]

Mercury in Medicine—Taking Unnecessary Risks: Committee on Government Reform (House) Subcommittee on Human Rights and Wellness, E1012-E1030 [21MY]

Reports filed

Animal Drug User Fee Act: Committee on Energy and Commerce (House) (H.R. 1260) (H. Rept. 108-287), H9032 [30SE]

———Committee on Health, Education, Labor, and Pensions (Senate) (S. 313) (S. Rept. 108-51), S6851 [21MY]

Biodefense Improvement and Treatment for America Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 15), S4375 [25MR]

Child Medication Safety Act: Committee on Education and the Workforce (House) (H.R. 1170) (H. Rept. 108-121), H4527 [21MY]

Consideration of Conference Report on H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act: Committee on Rules (House) (H. Res. 463) (H. Rept. 108-394), H12306 [21NO]

Consideration of H.R. 1, Medicare Prescription Drug and Modernization Act and H.R. 2596, Health Savings and Affordability Act: Committee on Rules (House) (H. Res. 299) (H. Rept. 108-181), H5928 [25JN]

Consideration of H.R. 1298, U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act: Committee on Rules (House) (H. Res. 210) (H. Rept. 108-80), H3569 [30AP]

Consideration of H.R. 2427, Pharmaceutical Market Access Act: Committee on Rules (House) (H. Res. 335) (H. Rept. 108-231), H7453 [23JY]

Foreign Assistance Programs Appropriations: Committee on Foreign Relations (Senate) (S. 1161) (S. Rept. 108-56), S7187 [2JN]

Medicare Prescription Drug, Improvement, and Modernization Act: Committee of Conference (H.R. 1) (H. Rept. 108-391), H11700 [20NO]

Medicare Prescription Drug and Modernization Act: Committee on Energy and Commerce (House) (H.R. 2473) (H. Rept. 108-178), H5927 [25JN]

———Committee on Ways and Means (House) (H.R. 2473) (H. Rept. 108-178), H6867 [15JY]

Mentally Ill Offender Treatment and Crime Reduction Act: Committee on the Judiciary (Senate) (S. 1194), S13133 [23OC]

Native American Alcohol and Substance Abuse Program Consolidation Act: Committee on Indian Affairs (Senate) (S. 285) (S. Rept. 108-75), S8125 [18JN]

Office of National Drug Control Policy Reauthorization: Committee on Government Reform (House) (H.R. 2086) (H. Rept. 108-167), H5661 [19JN]

———Committee on the Judiciary (House) (H.R. 2086) (H. Rept. 108-167), H6705 [14JY]

Patient Safety and Quality Improvement Act: Committee on Energy and Commerce (House) (H.R. 663) (H. Rept. 108-28), H1678 [6MR]

———Committee on Health, Education, Labor, and Pensions (Senate) (S. 720) (S. Rept. 108-196), S14964 [17NO]

Pediatric Research Equity Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 650) (S. Rept. 108-84), S8722 [26JN]

Pharmacy Education Aid Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 648) (S. Rept. 108-189), S14176 [6NO]

Poison Prevention Assistance and Regional Poison Control Centers Funding Stabilization: Committee on Health, Education, Labor, and Pensions (Senate) (S. 686) (S. Rept. 108-68), S7717 [11JN]

Prescription Drug and Medicare Improvement Act: Committee on Finance (Senate) (S. 1), S7876 [13JN]

Same-Day Consideration of H. Res. 463, Consideration of Conference Report on H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act: Committee on Rules (House) (H. Res. 459) (H. Rept. 108-390), H11700 [20NO]

U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act: Committee on International Relations (House) (H.R. 1298) (H. Rept. 108-60), H2863 [7AP]

Statements

Catholic Church Efforts To Combat Drug Abuse: Holy See, E2345 [20NO]

Studies

Coordination of Care for Those With Multiple Chronic Conditions, S8620 [26JN]

Summaries

Biological, Chemical and Radiological Weapons Countermeasures Research Act (S. 666), S4016 [19MR]

Defense of Medicare and Real Medicare Prescription Drug Benefit Act (S. 1992), S16128 [9DE]

Office of National Drug Control Policy Reauthorization (S. 1860), S14812-S14814 [12NO]

Prescription Drug and Medicare Improvement Act (S. 1): Specter Amendment on Advance Directives, S8653 [26JN]

———Specter Amendment on Coordination of Benefits for Prescription Drug Plans and State Pharmaceutical Assistance Programs, S8654 [26JN]

———Specter Amendment on Permanent Lifestyle Modification Program, S8653 [26JN]

———Specter Amendment on Physician Fee Schedule Payments, S8653 [26JN]

Tables

Depts. of Labor, HHS, and Education, and related agencies appropriations (H.R. 2660): HIV/AIDS funding, S11222 [9SE]

Global HIV/AIDS funding, S11222 [9SE]

HIV/AIDS, malaria, and tuberculosis initiatives funding, S9549 [17JY]

HIV/AIDS program funding levels, S11222 [9SE]

Immunization programs funding, S11232 [9SE]

Pharmaceutical company contributions by party (2002), H5912 [25JN]

Projected U.S. spending for global HIV/AIDS initiatives (2004-2008), S9549 [17JY]

U.S., Canadian negotiated Dept. of Veterans Affairs and Dept. of Defense prescription drug prices, H5912 [25JN]

Vaccines containing thimerosal, H8259 [16SE]

Testimonies

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization) Funding: Elton John, S6498 [15MY]

———Senator Sessions, S6498 [15MY]

Prescription Drug and Medicare Improvement Act: Committee on Finance (Senate), S8661 [26JN]

Texts of

H. Con. Res. 147, anniversary of Orphan Drug Act and National Organization for Rare Disorders, H4215 [19MY]

H. Res. 210, consideration of H.R. 1298, U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, H3575 [1MY]

H. Res. 299, consideration of H.R. 1, Medicare Prescription Drug and Modernization Act and H.R. 2596, Health Savings and Affordability Act, H5952 [26JN]

H. Res. 335, consideration of H.R. 2427, Pharmaceutical Market Access Act, H7531 [24JY]

H. Res. 459, same-day consideration of H. Res. 463, consideration of conference report on H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act, H12174 [21NO]

H. Res. 463, consideration of conference report on H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act, H12230 [21NO]

H.R. 1, Medicare Prescription Drug and Modernization Act, H6007-H6077 [26JN]

H.R. 1, Prescription Drug and Medicare Improvement Act, S8898-S8997 [7JY]

H.R. 663, Patient Safety and Quality Improvement Act, H1766-H1771 [12MR]

H.R. 1170, Child Medication Safety Act, H4382 [21MY]

H.R. 1260, Animal Drug User Fee Act, H9054-H9057 [1OC]

H.R. 1298, U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, H3588-H3596 [1MY]

H.R. 1463, Smallpox Emergency Personnel Protection Act, H2478-H2480 [31MR]

H.R. 1770, Smallpox Emergency Personnel Protection Act, H3340-H3343 [11AP]

H.R. 2086, Office of National Drug Control Policy reauthorization, H8962-H8966 [30SE]

H.R. 2427, Pharmaceutical Market Access Act, H7595 [24JY]

H.R. 2631, ensure prescription drug coverage for Federal Employees Health Benefits Program Medicare-eligible enrollees is actuarially equal to benefit offered to general enrollees, H6303 [8JY]

S. 1, Prescription Drug and Medicare Improvement Act, S7720 [11JN]

S. 41, repeal certain Homeland Security Act provisions, S47 [7JA]

S. 54, Greater Access to Affordable Pharmaceuticals Act, S55-S58 [7JA]

S. 105, repeal certain Homeland Security Act provisions relative to pediatric vaccine manufacturer liability, S81 [7JA]

S. 178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act, S1071 [16JA]

S. 285, Native American Alcohol and Substance Abuse Program Consolidation Act, S1886-S1888 [4FE], S9819-S9823 [23JY]

S. 313, Animal Drug User Fee Act, S7168-S7171 [23MY], S14279-S14282 [7NO], H10293-H10296 [4NO]

S. 371, require notification by manufacturers before discontinuing production of a vaccine and develop a national vaccine stockpile, S2357 [12FE]

S. 399, Campus Classmate Offenders in Rehabilitation and Treatment (CORT) Act, S2474 [13FE]

S. 406, Communities Combating College Drinking and Drug Use Act, S2482 [13FE]

S. 648, Pharmacy Education Aid Act, S16054-S16057 [25NO]

S. 650, Pediatric Research Equity Act, S3898-S3900 [18MR], S9811-S9813, S9816-S9818 [23JY], H11567-H11569 [19NO]

S. 686, poison prevention assistance and regional poison control centers funding stabilization, S8316 [20JN]

S. 686, provide assistance for poison prevention and stabilize funding of regional poison control centers, S4287 [21MR], S16201 [9DE], H11574 [19NO]

S. 778, Medicare Rx Drug Discount and Security Act, S4828-S4834 [3AP]

S. 948, Drug Company Gift Disclosure Act, S5494 [29AP]

S. 1002, Amateur Sports Integrity Act, S5785 [6MY]

S. 1138, Help Expand Access to Recovery and Treatment (HEART) Act, S7051-S7053 [22MY]

S. 1153, Veterans Prescription Drugs Assistance Act, S7148 [23MY]

S. 1194, Mentally Ill Offender Treatment and Crime Reduction Act, S7484-S7486 [5JN], S13320-S13322 [27OC]

S. 1780, Anabolic Steroid Control Act, S13141 [23OC]

S. 1784, Methamphetamine Blister Pack Loophole Elimination Act, S13147 [23OC]

S. 1907, Rural Safety Act, S15297-S15299 [20NO]

S. 1974, Medicare Preservation and Drug Price Fairness Act, S16022 [25NO]

S. 1994, Efficiency in Government Health Care Spending Act, S16133 [9DE]

S. 1995, repeal Medicare Advantage Regional Plan Stabilization Fund, S16133 [9DE]

S. Con. Res. 46, corrections in enrollment of H.R. 1298, U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, S6717, S6786 [20MY], S6918 [22MY], H4382 [21MY]

S. Con. Res. 80, urge Japan to honor commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, S14364 [10NO]

S. Res. 109, combat polio, S4974 [8AP]

S. Res. 260, Dept. of HHS action to remove dietary supplements containing ephedrine alkaloids from the market, S14180 [6NO]

S. Res. 263, DEA anniversary, S14274 [7NO]

S. Res. 266, combat polio, S14817 [12NO], S15303 [20NO]

S. Res. 278, reevaluate necessity and safety of anthrax and smallpox vaccinations for troops, S16031 [25NO]